SuperGen News
Most Popular SuperGen Story
SuperGen shares slide on late-stage Dacogen failure
Shares of SuperGen took a dive this morning after the company revealed that Dacogen failed a late-stage trial for the bone marrow disease MDS. Researchers say the drug failed to improve the median... Read more...
Latest Headlines
- October 26, 2009
- October 10, 2006
- July 5, 2006
- July 5, 2006
- June 21, 2006
- May 2, 2006
- April 25, 2006
- February 1, 2006
- January 26, 2006
- November 14, 2005
- October 26, 2005
- September 27, 2005
- September 1, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
